10 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 10 of 10 clinical reviews.
A guide covering how tadalafil (Cialis) affects school performance, physical activity, and daily routines in adolescents aged 12 to 17, with dosing context, side-effect management, and activity restrictions.
A guide for caregivers helping older adults take tadalafil (Cialis) safely, covering dosing, drug interactions, fall risk, and when to call the prescriber.
A clinical review of tadalafil's effects on adolescent development, covering approved pediatric indications, hormonal interactions, bone and cardiovascular safety, and what parents and prescribers need to know.
A guide to how tadalafil (Cialis) affects older adults, covering pharmacokinetics, cardiovascular safety, dosing adjustments, and quality-of-life outcomes in men and women aged 65+.
A guide to tadalafil use in patients 65 and older, covering FDA-approved indications, off-label applications, age-related pharmacokinetics, drug interactions, and safety data from key clinical trials.
A guide to tadalafil use in adults aged 65 and older, covering dosing adjustments, drug interactions, cardiovascular safety, BPH management, and the transition from pediatric or adult urology care into geriatric-appropriate protocols.
A clinical guide for parents and caregivers on how tadalafil affects daily school performance, physical activity, and safety monitoring in children under age 12, prepared by the HealthRX.com Editorial Team.
A guide to tadalafil use in pediatric patients under age 12, covering approved indications, dosing evidence, safety monitoring, and structured transition planning for adolescent and adult care handoff.
A guide to off-label tadalafil use in children under 12, covering pulmonary arterial hypertension, dosing data, trial evidence, safety signals, and how prescribers manage a drug with no FDA pediatric label for this age group.
A clinical review of tadalafil off-label prescribing in adolescents ages 12 to 17, covering approved vs. Unapproved indications, evidence from pediatric trials, dosing considerations, safety data, and regulatory context.